Product Compliance And Certification For Cosmetic Product In South Korea

Scope and evidence must be confirmed before any paid tests or filings.

A Korean cosmetic launch is not decided by one universal “cosmetic certificate”. First decide whether the exact formulation, intended use and Korean claims remain within cosmetics; then distinguish ordinary from functional cosmetics, identify the registered Korean responsible seller and clear ingredient, import, batch-release and label gates. An overseas approval or ISO/GMP certificate does not replace these Korean steps.

Three questions that determine the route

Cosmetic or another regulated product?

Record where the product is used, how it acts and every front-pack, website and influencer claim. The Cosmetics Act concerns products with a mild effect applied to the human body for cleansing, beautifying or maintaining skin or hair. Claims of treating disease or pharmacological action can require reassessment under medicines or other rules; a product name alone is not a classification.

Ordinary or functional cosmetic?

Check claims of skin whitening, wrinkle reduction, UV protection/tanning, qualifying hair colouring or bleaching, hair-loss symptom relief and depilation against MFDS functional-cosmetics categories and their exclusions. The list also covers certain acne, atopic-prone skin dryness and stretch-mark claims. Ordinary “hair nourishment” is not automatically a functional-cosmetic category. A functional cosmetic requires product-specific MFDS examination or, where the precise conditions are met, a report; marketing vocabulary alone does not classify it.

Local manufacture, standard import or special channel?

A Korean manufacturer, an imported finished product, a parallel import and an in-store mixed/refilled product do not have the same operational chain. Identify the actual importer, sales channel, brand owner and who performs batch acceptance before selecting paperwork.

Product-to-regime matrix: what opens each gate

Apply each applicable row cumulatively: import clearance is not functional-cosmetic authorization, and either one is not release of a compliant retail batch.

Product or transaction trigger	Regulatory layer and responsible action	Do not release until
Ordinary cosmetic with cosmetic-only claims	Cosmetics Act, ingredient restrictions, responsible-seller obligations and Korean retail labeling; no blanket MFDS product approval is assumed.	Classification, formula and advertising review are recorded.
SPF, whitening, anti-wrinkle or another qualifying function	Functional-cosmetic route: MFDS product examination or report where the specified criteria allow it. Determine which route applies to this SKU and change history.	The relevant examination outcome or accepted report and matching claims are established.
Disease-treatment, drug-like or otherwise borderline promise	Reassess the product classification with Korean specialist/MFDS before relying on cosmetic procedures; different legislation may apply.	The competent regime is confirmed; no cosmetic shortcut is presumed.
Commercial import of finished cosmetics	Registered responsible seller/importer plus KPTA standard import notification before customs clearance; batch-wise quality checks and Korean retail labeling before sale.	Shipment paperwork, testing and label gates are complete.
Parallel imports; shop mixing/refill; products for infants/children	Extra identity-verification, customized-cosmetics or infant/child safety-information checks may apply depending on precise model and marketing.	The specific exception or additional duty has been tested rather than assumed away.

Do not treat the final row as one shared exemption. For parallel imports, KPTA describes a separate lot-identity verification before the standard import notification. Where a product is specifically labeled or advertised for infants or children, Cosmetics Act Article 4-2 requires the responsible seller to prepare and retain product-specific safety and quality supporting information; the applicable age, advertising and retention details must be checked in the Enforcement Rule. Mixing or refilling for a customer is a separate customized-cosmetics business question. Decide each branch from the actual sales model.

Who holds each decision and record?

The foreign factory supplies traceable formula, manufacturing and test evidence. The Korean registered responsible cosmetics seller controls local distribution compliance and release records; the customs declarant/importer coordinates shipment steps. MFDS governs functional-cosmetic examination/report and cosmetics oversight, while KPTA administers the standard import notification process described in its published guidance. Contracts should identify owners of artwork, claims, ingredient updates, complaints and recall communications; contractual allocation does not cancel statutory duties.

SKU evidence pack before the label is printed

Final quantitative formula, ingredient identities and functions, including preservatives, pigments, UV filters and restricted substances; compare with the current Korean prohibited/restricted lists.
Finished-product identity: SKU, format, intended application site, directions, target users and Korean/foreign claims inventory including ecommerce.
Product specifications, suitable test methods, manufacturing/batch traceability and quality records; decide which tests support each lot release.
For functional claims: exact function, evidence, applicable MFDS review/report route and documentation for SPF/PA or other substantiation when relevant.
For imports: responsible-seller registration particulars, manufacturer and sale certificates and any conditional supporting documents specified in KPTA instructions.
Proposed primary/outer packaging artwork, Korean ingredient presentation, precautions, lot number, use-by or period-after-opening and price-display arrangements.
Named decision owners and a signed classification/claims decision, including open questions to be confirmed with MFDS or the importer.

Retail labeling and advertising: two distinct compliance checks

Article 10 of the Cosmetics Act specifies information for packaging, including product name, business details, ingredients subject to statutory exceptions, net quantity, batch, shelf-life/period after opening, price, precautions and functional-cosmetic indication where applicable. Primary-versus-outer pack placement and limited small-pack exceptions matter. KPTA guidance says imported products need Korean-language presentation before sale; a foreign-language label by itself is not the release test.

Where the period after opening is used instead of an expiry date, Article 10 also requires the manufacturing date alongside it; verify which pack bears each particular.

Article 13 separately restricts misleading and medicine-like advertising and claims implying unapproved functional status. Check the website, product detail page, influencer scripts and package together. A test report may support a claim but is not itself an MFDS authorization. Do not present private testing, ISO certification or GMP documentation as a universal government-issued cosmetic certification.

Launch dependency chain with stop/go gates

Freeze one SKU and its proposed Korean claims; determine cosmetic scope and ordinary/functional/borderline status.
Appoint or verify the Korean responsible seller; confirm importer and distribution model, including any special retail channel.
Screen every formula ingredient against current Korean lists; assemble specification, provenance and substantiation evidence.
If functional, complete the applicable MFDS examination or report route before using the functional status and claims.
If imported, complete KPTA standard import notification before clearance; after clearance, verify batch-wise quality results and Korean label before offering for sale.
Retain lot and advertising records; monitor safety signals, complaints, legislative changes and product modifications.

Change control: four events that reopen the assessment

Changing an active, restricted ingredient, concentration, UV filter or colourant: rerun formula legality and evidence checks.
Adding SPF, whitening, anti-wrinkle, hair-loss or disease-related claims: reconsider functional status or a different legal regime.
Switching manufacturer, responsible seller, importer, batch process or shipping channel: reassess registrations, import evidence and quality controls.
Redesigning primary/outer pack, shelf-life, use instructions or online listing: redo Korean labeling and advertising review.

Rules in transition: avoid premature compliance claims

Law No. 21302, promulgated on 30 December 2025, has a general commencement of 31 December 2026. Its supplementary provisions, however, defer the new product-specific safety-assessment duty according to the responsible seller’s circumstances. For a seller with annual production plus import value of at least KRW 1 billion, or one registered after promulgation, the statutory categories are:

1 January 2028: products examined or reported as functional cosmetics after promulgation.
1 January 2030: products first manufactured or imported and launched after promulgation, under the separately specified new-product category.
1 January 2031: remaining products in that seller group. The Act also sets 1 January 2031 for sellers below KRW 1 billion; however, a seller newly registered after promulgation may fall into the earlier-registration category irrespective of value. Resolve overlapping conditions against the statutory transition text.

These are conditional statutory application dates, not three universal deadlines for every cosmetic. The amendment specifies how annual value is determined and when a provision first applies to manufactured or imported goods. In the version of the Act effective 8 October 2026, infant/child-directed product safety records are governed by Article 4-2; the amendment renumbers those rules to Article 4-3, with a further specified change to Article 4-3 taking effect on 1 January 2029. MFDS describes rollout beginning in 2028, but does not turn a pending safety-file duty into a universal product approval certificate. Verify the applicable seller tier, SKU history and transitional rule before launch.

When to use the narrower product maps

This page resolves the cross-category Korean route for an unspecified cosmetic SKU. For formula-specific issues, use the following adjacent pages rather than assuming every cosmetic is a face cream or hair dye:

FAQ: route decisions that change the launch

Does every cosmetic product need an MFDS approval certificate?

No blanket product approval follows merely from being an ordinary cosmetic. The legal business, ingredient, quality, label and—if imported—shipment requirements still apply. Functional cosmetics have a separate examination or report decision.

Can the foreign brand import through any reseller without a Korean responsible seller?

Do not assume so. Commercially imported cosmetics distributed for sale involve a registered Korean responsible cosmetics seller under the Cosmetics Act and KPTA import process. Confirm the contractual operator and each entity’s status.

Does adding “SPF 50” only to the website avoid the functional-cosmetic route?

No. Digital product claims are part of the classification and advertising review. Check the formula, SPF/PA evidence and whether MFDS examination or the permitted report route is required before publishing the claim.

May imported stock be sold immediately after Korean customs clearance?

Clearance alone is not a retail-release decision. KPTA instructs that imported cosmetics undergo batch-number-based quality inspection and compliant Korean labeling before sale.

Does EU compliance or a factory ISO/GMP certificate settle Korean labeling and formula legality?

No. It may be useful supporting evidence, but Korean prohibited/restricted ingredient rules, functional classification, responsible-seller status and label rules need their own checks.

Official sources and verification limits

Primary reference points are the Korean Cosmetics Act (version effective 8 October 2026), the current MFDS cosmetic safety standards, MFDS functional-cosmetics guidance, KPTA import instructions and the MFDS statement on the planned 2028 safety-assessment phase-in. Review consolidated provisions and notices again for the exact launch date.